Catalyst
Slingshot members are tracking this event:
Genocea (GNCA) Presents 12-Month Phase 2a Data Evaluating GEN-003 in Treatment of Genital Herpes at the Infections Disease Society of America Annual Meeting
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| GNCA |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Oct 28, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
12-month Data, Phase 2a, Gen-003, Genital Herpes, Infectious Disease Society Of America, Annual Meeting
